India's Decade of Collaboration
Harvard Business Review
MAY 31, 2011
Biocon also sources drug molecules from other partners, especially from developing countries, such as the Cuba-based Center of Molecular Immunology (CMI). The vision and purpose of Kiran Mazumdar-Shaw , chairman and managing director of Biocon, is to deliver affordable drugs to the masses in both India and other markets.
Let's personalize your content